Loading ...It’s a good start but don’t think it’s good publicity under the circumstances.
The reason is they still don’t get the right treatment and once the patient is in the critical stage the Ivermectin ALONE will likely not be enough.
They will then use it against them saying see it doesn’t work.
I don’t know if they understand it. Like the Hydroxy trials they gave in critical patients. They didn’t give it on outpatient when the virus was multiplying which days later caused the immune reaction and inflammation stage.
Although unlike Hydroxy Ivermectin helps in all stages and has anti inflammatory effects still in critical care higher initial doses of steroids are needed as well as other components they won’t give.
Ipso 13:46
No Comments
No comments yet.
RSS feed for comments on this post.
Sorry, the comment form is closed at this time.